Xun Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xun Tan has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Jing Yang
Zhejiang University
5 shared publicationsHuiwen Ye
Zhejiang University
4 shared publicationsRui Liu
Department of Veterinary Medicine, Zhejiang University, Hangzhou, China
3 shared publications- Rui Liu
Department of Veterinary Medicine, Zhejiang University, Yuhangtang Road 866, Hangzhou 310058, China
3 shared publications Xia Liu
Zhejiang University
3 shared publications- Yi-Tian Ying
Department of Veterinary Medicine, Zhejiang University, Yuhangtang Road 866, Hangzhou 310058, China
3 shared publications
Latest Publications
- 29 October 2026
- Published by Taylor & Francis in Autophagy
- p. 1-3
Mitochondrial membrane rupture licenses prohibitin 2-mediated bacterial tethering and E3 ligase recruitment to drive mito-xenophagy
Although ubiquitination is required for the recognition of invading bacteria by selective autophagy receptors and subsequent lysosomal destruction (xenophagy), how the host ubiquitin machinery is recruited to intracellular pathogens remains incompletely understood. In our recent study, we revealed that mitochondrial injury serves as an indispensable licensing checkpoint for antibacterial xenophagy. Outer mitochondrial membrane rupture externalizes inner membrane-anchored PHB2/prohibitin 2, which tethers damaged mitochondria to bacteria by engaging PHB (prohibitin) domain-containing proteins on the bacterial cell wall. Concurrently, PHB2 recruits the E3 ligase ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1) or PRKN/Parkin - two well-characterized mitophagy-associated enzymes - which undergo auto-ubiquitination to assemble a localized polyubiquitin coat, ultimately driving organelle-bacterial co-autophagy (mito-xenophagy) independent of canonical mitophagy.
- 29 October 2026
- Published by Taylor & Francis in Autophagy
- p. 1-3
Mitochondrial membrane rupture licenses prohibitin 2-mediated bacterial tethering and E3 ligase recruitment to drive mito-xenophagy
Although ubiquitination is required for the recognition of invading bacteria by selective autophagy receptors and subsequent lysosomal destruction (xenophagy), how the host ubiquitin machinery is recruited to intracellular pathogens remains incompletely understood. In our recent study, we revealed that mitochondrial injury serves as an indispensable licensing checkpoint for antibacterial xenophagy. Outer mitochondrial membrane rupture externalizes inner membrane-anchored PHB2/prohibitin 2, which tethers damaged mitochondria to bacteria by engaging PHB (prohibitin) domain-containing proteins on the bacterial cell wall. Concurrently, PHB2 recruits the E3 ligase ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1) or PRKN/Parkin - two well-characterized mitophagy-associated enzymes - which undergo auto-ubiquitination to assemble a localized polyubiquitin coat, ultimately driving organelle-bacterial co-autophagy (mito-xenophagy) independent of canonical mitophagy.
- 27 October 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (44) , 34915-34932
l -Arginine Ameliorates IBS-D by Modulating the Ligilactobacillus murinus –LCA–FXR/eNOS Signaling Axis
L-Arginine is a semiessential amino acid with diverse metabolic functions and has been implicated in gastrointestinal health through interactions with the gut microbiota; however, its therapeutic potential in diarrhea-predominant irritable bowel syndrome (IBS-D) remains unclear. Here, an IBS-D mouse model was established in C57BL/6J mice, and multiomics analyses combined with in vivo and in vitro validation were performed to investigate the mechanisms underlying l-arginine-mediated protection. l-Arginine supplementation significantly alleviated IBS-D-like symptoms and improved intestinal barrier function. Transcriptomic analysis revealed the activation of the FXR/PI3K/AKT/eNOS signaling pathway, which was associated with enhanced nitric oxide production. Integrated metagenomic and transcriptomic analyses identified Ligilactobacillus murinus (L. murinus) as a key microbiota component associated with bile acid metabolism and eNOS expression. Furthermore, L. murinus transplantation reproduced the beneficial effects of l-arginine, and metabolomic analysis identified lithocholic acid (LCA) as a microbiota-derived metabolite involved in this process. In vitro experiments demonstrated that LCA alleviated lipopolysaccharide-induced epithelial inflammation and barrier dysfunction via FXR/eNOS activation. Collectively, these findings reveal that l-arginine ameliorates IBS-D through microbiota remodeling, LCA-mediated bile acid regulation, and activation of the colonic FXR/PI3K/AKT/eNOS axis, highlighting its potential as a microbiota-targeted therapeutic strategy.
- 27 October 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (44) , 34915-34932
l -Arginine Ameliorates IBS-D by Modulating the Ligilactobacillus murinus –LCA–FXR/eNOS Signaling Axis
L-Arginine is a semiessential amino acid with diverse metabolic functions and has been implicated in gastrointestinal health through interactions with the gut microbiota; however, its therapeutic potential in diarrhea-predominant irritable bowel syndrome (IBS-D) remains unclear. Here, an IBS-D mouse model was established in C57BL/6J mice, and multiomics analyses combined with in vivo and in vitro validation were performed to investigate the mechanisms underlying l-arginine-mediated protection. l-Arginine supplementation significantly alleviated IBS-D-like symptoms and improved intestinal barrier function. Transcriptomic analysis revealed the activation of the FXR/PI3K/AKT/eNOS signaling pathway, which was associated with enhanced nitric oxide production. Integrated metagenomic and transcriptomic analyses identified Ligilactobacillus murinus (L. murinus) as a key microbiota component associated with bile acid metabolism and eNOS expression. Furthermore, L. murinus transplantation reproduced the beneficial effects of l-arginine, and metabolomic analysis identified lithocholic acid (LCA) as a microbiota-derived metabolite involved in this process. In vitro experiments demonstrated that LCA alleviated lipopolysaccharide-induced epithelial inflammation and barrier dysfunction via FXR/eNOS activation. Collectively, these findings reveal that l-arginine ameliorates IBS-D through microbiota remodeling, LCA-mediated bile acid regulation, and activation of the colonic FXR/PI3K/AKT/eNOS axis, highlighting its potential as a microbiota-targeted therapeutic strategy.
- 26 June 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 371, 122061
Tong-Xie-Yao-Fang ameliorates IBS-D: Potential role of Alistipes finegoldii-associated gut tryptophan indole metabolism
- 26 June 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 371, 122061
Tong-Xie-Yao-Fang ameliorates IBS-D: Potential role of Alistipes finegoldii-associated gut tryptophan indole metabolism
- Open Access
- 28 May 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (6) , 117463
Prohibitin 2 links damaged mitochondria to intracellular bacteria to trigger xenophagy independent of mitophagy
- 28 May 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (6) , 117463
Open AccessProhibitin 2 links damaged mitochondria to intracellular bacteria to trigger xenophagy independent of mitophagy
- Open Access
- 21 March 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Reduction in microbiota-derived short-chain fatty acids contributes to the pathogenesis of pulmonary arterial hypertension
- 21 March 2026
- Published by Springer Nature in Respiratory Research
- Vol. 27 (1)
Open AccessReduction in microbiota-derived short-chain fatty acids contributes to the pathogenesis of pulmonary arterial hypertension
- 11 June 2025
- Published by Elsevier in Food Bioscience
- Vol. 70
Piperine confers protection against pulmonary arterial hypertension by targeting IL-6/STAT3 signaling pathway
- 11 June 2025
- Published by Elsevier in Food Bioscience
- Vol. 70
Piperine confers protection against pulmonary arterial hypertension by targeting IL-6/STAT3 signaling pathway
- 4 April 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (9) , 1962-1975
Staphylococcus aureus reprograms CASP8 (caspase 8) signaling to evade cell death and Xenophagy
Regulated cell death and xenophagy constitute fundamental cellular mechanisms against invading microorganisms. Staphylococcus aureus, a notorious pathogen, can invade and persist within host cells for extended periods. Here, we describe a novel mechanism by which S. aureus subverts these host defenses through the manipulation of the CASP8 (caspase 8) signaling pathway. Upon invasion, S. aureus triggers the assembly of a RIPK3 (receptor interacting serine/threonine kinase 3) complex to induce CASP8 autoprocessing. However, the bacterium inhibits CUL3 (cullin 3)-dependent K63-linked ubiquitination, leading to an atypical activation of CASP8. This non-canonical activation does not initiate the CASP8-CASP3 cascade but instead suppresses RIPK3-dependent necroptosis, a regulated cell death pathway typically activated when apoptosis fails. The resulting non-apoptotic, cleaved CASP8 redirects its enzymatic activity toward cleaving SQSTM1/p62, a selective macroautophagy/autophagy receptor, thus enabling S. aureus to evade antimicrobial xenophagy. The results of this study suggest that S. aureus reprograms the CASP8 signaling pathway from inducing cell death to preserving cell survival and inhibiting xenophagy, a critical strategy that supports its stealthy replication and persistence within host cells.
- 4 April 2025
- Published by Taylor & Francis in Autophagy
- Vol. 21 (9) , 1962-1975
Staphylococcus aureus reprograms CASP8 (caspase 8) signaling to evade cell death and Xenophagy
Regulated cell death and xenophagy constitute fundamental cellular mechanisms against invading microorganisms. Staphylococcus aureus, a notorious pathogen, can invade and persist within host cells for extended periods. Here, we describe a novel mechanism by which S. aureus subverts these host defenses through the manipulation of the CASP8 (caspase 8) signaling pathway. Upon invasion, S. aureus triggers the assembly of a RIPK3 (receptor interacting serine/threonine kinase 3) complex to induce CASP8 autoprocessing. However, the bacterium inhibits CUL3 (cullin 3)-dependent K63-linked ubiquitination, leading to an atypical activation of CASP8. This non-canonical activation does not initiate the CASP8-CASP3 cascade but instead suppresses RIPK3-dependent necroptosis, a regulated cell death pathway typically activated when apoptosis fails. The resulting non-apoptotic, cleaved CASP8 redirects its enzymatic activity toward cleaving SQSTM1/p62, a selective macroautophagy/autophagy receptor, thus enabling S. aureus to evade antimicrobial xenophagy. The results of this study suggest that S. aureus reprograms the CASP8 signaling pathway from inducing cell death to preserving cell survival and inhibiting xenophagy, a critical strategy that supports its stealthy replication and persistence within host cells.
- Open Access
- 19 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4489
Dysregulated VEGF/VEGFR-2 Signaling and Plexogenic Lesions in the Embryonic Lungs of Chickens Predisposed to Pulmonary Arterial Hypertension
Plexiform lesions are a hallmark of pulmonary arterial hypertension (PAH) in humans and are proposed to stem from dysfunctional angioblasts. Broiler chickens (Gallus gallus) are highly susceptible to PAH, with plexiform-like lesions observed in newly hatched individuals. Here, we reported the emergence of plexiform-like lesions in the embryonic lungs of broiler chickens. Lung samples were collected from broiler chickens at embryonic day 20 (E20), hatch, and one-day-old, with PAH-resistant layer chickens as controls. Plexiform lesions consisting of CD133+/vascular endothelial growth factor receptor type-2 (VEGFR-2)+ angioblasts were exclusively observed in broiler embryos and sporadically in layer embryos. Distinct gene profiles of angiogenic factors were observed between the two strains, with impaired VEGF-A/VEGFR-2 signaling correlating with lesion development and reduced arteriogenesis. Pharmaceutical inhibition of VEGFR-2 resulted in enhanced lesion development in layer embryos. Moreover, broiler embryonic lungs displayed increased activation of HIF-1α and nuclear factor erythroid 2-related factor 2 (Nrf2), indicating a hypoxic state. Remarkably, we found a negative correlation between lung Nrf2 activation and VEGF-A and VEGFR-2 expression. In vitro studies indicated that Nrf2 overactivation restricted VEGF signaling in endothelial progenitor cells. The findings from broiler embryos suggest an association between plexiform lesion development and impaired VEGF system due to aberrant activation of Nrf2.
- 19 April 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (8) , 4489
Open AccessDysregulated VEGF/VEGFR-2 Signaling and Plexogenic Lesions in the Embryonic Lungs of Chickens Predisposed to Pulmonary Arterial Hypertension
Plexiform lesions are a hallmark of pulmonary arterial hypertension (PAH) in humans and are proposed to stem from dysfunctional angioblasts. Broiler chickens (Gallus gallus) are highly susceptible to PAH, with plexiform-like lesions observed in newly hatched individuals. Here, we reported the emergence of plexiform-like lesions in the embryonic lungs of broiler chickens. Lung samples were collected from broiler chickens at embryonic day 20 (E20), hatch, and one-day-old, with PAH-resistant layer chickens as controls. Plexiform lesions consisting of CD133+/vascular endothelial growth factor receptor type-2 (VEGFR-2)+ angioblasts were exclusively observed in broiler embryos and sporadically in layer embryos. Distinct gene profiles of angiogenic factors were observed between the two strains, with impaired VEGF-A/VEGFR-2 signaling correlating with lesion development and reduced arteriogenesis. Pharmaceutical inhibition of VEGFR-2 resulted in enhanced lesion development in layer embryos. Moreover, broiler embryonic lungs displayed increased activation of HIF-1α and nuclear factor erythroid 2-related factor 2 (Nrf2), indicating a hypoxic state. Remarkably, we found a negative correlation between lung Nrf2 activation and VEGF-A and VEGFR-2 expression. In vitro studies indicated that Nrf2 overactivation restricted VEGF signaling in endothelial progenitor cells. The findings from broiler embryos suggest an association between plexiform lesion development and impaired VEGF system due to aberrant activation of Nrf2.
- Open Access
- 23 October 2022
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-18
Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion
Background: Plexiform lesions, which have a dynamic appearance in structure and cellular composition, are the histological hallmark of severe pulmonary arterial hypertension in humans. The pathogenesis of the lesion development remains largely unknown, although it may be related to local inflammation and dysfunction in early progenitor endothelial cells (eEPCs). We tested the hypothesis that eEPCs contribute to the development of plexiform lesions by differentiating into macrophages in the setting of chronic inflammation. Methods: The eEPC markers CD133 and VEGFR-2, macrophage lineage marker mannose receptor C-type 1 (MRC1), TNFα and nuclear factor erythroid 2-related factor 2 (Nrf2) in plexiform lesions in a broiler model were determined by immunohistochemistry. eEPCs derived from peripheral blood mononuclear cells were exposed to TNFα, and macrophage differentiation and angiogenic capacity of the cells were evaluated by phagocytotic and Matrigel plug assays, respectively. The role of Nrf2 in eEPC-to-macrophage transition as well as in MRC1 expression was also evaluated. Intratracheal installation of TNFα was conducted to determine the effect of local inflammation on the formation of plexiform lesions. Results: Cells composed of the early lesions have a typical eEPC phenotype whereas those in more mature lesions display molecular and morphological characteristics of macrophages. Increased TNFα production in plexiform lesions was observed with lesion progression. In vitro studies showed that chronic TNFα challenge directed eEPCs to macrophage differentiation accompanied by hyperactivation of Nrf2, a stress-responsive transcription factor. Nrf2 activation (Keap1 knockdown) caused a marked downregulation in CD133 but upregulation in MRC1 mRNA. Dual luciferase reporter assay demonstrated that Nrf2 binds to the promoter of MRC1 to trigger its expression. In good agreement with the in vitro observation, TNFα exposure induced macrophage differentiation of eEPCs in Matrigel plugs, resulting in reduced neovascularization of the plugs. Intratracheal installation of TNFα resulted in a significant increase in plexiform lesion density. Conclusions: This work provides evidence suggesting that macrophage differentiation of eEPCs resulting from chronic inflammatory stimulation contributes to the development of plexiform lesions. Given the key role of Nrf2 in the phenotypic switching of eEPCs to macrophages, targeting this molecular might be beneficial for intervention of plexiform lesions.
- 23 October 2022
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-18
Open AccessPotential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion
Background: Plexiform lesions, which have a dynamic appearance in structure and cellular composition, are the histological hallmark of severe pulmonary arterial hypertension in humans. The pathogenesis of the lesion development remains largely unknown, although it may be related to local inflammation and dysfunction in early progenitor endothelial cells (eEPCs). We tested the hypothesis that eEPCs contribute to the development of plexiform lesions by differentiating into macrophages in the setting of chronic inflammation. Methods: The eEPC markers CD133 and VEGFR-2, macrophage lineage marker mannose receptor C-type 1 (MRC1), TNFα and nuclear factor erythroid 2-related factor 2 (Nrf2) in plexiform lesions in a broiler model were determined by immunohistochemistry. eEPCs derived from peripheral blood mononuclear cells were exposed to TNFα, and macrophage differentiation and angiogenic capacity of the cells were evaluated by phagocytotic and Matrigel plug assays, respectively. The role of Nrf2 in eEPC-to-macrophage transition as well as in MRC1 expression was also evaluated. Intratracheal installation of TNFα was conducted to determine the effect of local inflammation on the formation of plexiform lesions. Results: Cells composed of the early lesions have a typical eEPC phenotype whereas those in more mature lesions display molecular and morphological characteristics of macrophages. Increased TNFα production in plexiform lesions was observed with lesion progression. In vitro studies showed that chronic TNFα challenge directed eEPCs to macrophage differentiation accompanied by hyperactivation of Nrf2, a stress-responsive transcription factor. Nrf2 activation (Keap1 knockdown) caused a marked downregulation in CD133 but upregulation in MRC1 mRNA. Dual luciferase reporter assay demonstrated that Nrf2 binds to the promoter of MRC1 to trigger its expression. In good agreement with the in vitro observation, TNFα exposure induced macrophage differentiation of eEPCs in Matrigel plugs, resulting in reduced neovascularization of the plugs. Intratracheal installation of TNFα resulted in a significant increase in plexiform lesion density. Conclusions: This work provides evidence suggesting that macrophage differentiation of eEPCs resulting from chronic inflammatory stimulation contributes to the development of plexiform lesions. Given the key role of Nrf2 in the phenotypic switching of eEPCs to macrophages, targeting this molecular might be beneficial for intervention of plexiform lesions.
- Open Access
- 1 March 2022
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 2087-2101
MSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension
Purpose: Pulmonary arterial hypertension (PAH) is a progressive and fatal pulmonary vascular disease initiated by endothelial dysfunction. Mesenchymal stromal cells (MSCs) have been shown to ameliorate PAH in various rodent models; however, these models do not recapitulate all the histopathological alterations observed in human PAH. Broiler chickens (Gallus gallus) can develop PAH spontaneously with neointimal and plexogenic arteriopathy strikingly similar to that in human patients. Herein, we examined the protective effects of MSC transplantation on the development of PAH in this avian model. Methods: Mixed-sex broilers at 15 d of age were received 2× 106 MSCs or PBS intravenously. One day later, birds were exposed to cool temperature with excessive salt in their drinking water to induce PAH. Cumulative morbidity from PAH and right-to-left ventricle ratio were recorded. Lung histologic features were evaluated for the presence of endothelial damage, endothelial proliferation and plexiform lesions. Expression of proinflammatory mediators and angiogenic factors in the lung was detected. Matrigel tube formation assay was performed to determine the angiogenic potential of endogenous MSCs. Results: MSC administration reduced cumulative PAH morbidity and attenuated endothelial damage, plexiform lesions and production of inflammatory mediators in the lungs. No significant difference in the expression of paracrine angiogenic factors including VEGF-A and TGF-β was determined between groups, suggesting that they are not essential for the beneficial effect of MSC transplantation. Interestingly, the endogenous MSCs from birds receiving MSC transplantation demonstrated endothelial differentiatial capacity in vitro whereas those from the mock birds did not. Conclusion: Our results support the therapeutic use of MSC transplantation for PAH treatment and suggest that exogenous MSCs produce beneficial effects through modulating inflammation and endogenous MSC-mediated vascular repair. Graphical Abstract:
- 1 March 2022
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 2087-2101
Open AccessMSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension
Purpose: Pulmonary arterial hypertension (PAH) is a progressive and fatal pulmonary vascular disease initiated by endothelial dysfunction. Mesenchymal stromal cells (MSCs) have been shown to ameliorate PAH in various rodent models; however, these models do not recapitulate all the histopathological alterations observed in human PAH. Broiler chickens (Gallus gallus) can develop PAH spontaneously with neointimal and plexogenic arteriopathy strikingly similar to that in human patients. Herein, we examined the protective effects of MSC transplantation on the development of PAH in this avian model. Methods: Mixed-sex broilers at 15 d of age were received 2× 106 MSCs or PBS intravenously. One day later, birds were exposed to cool temperature with excessive salt in their drinking water to induce PAH. Cumulative morbidity from PAH and right-to-left ventricle ratio were recorded. Lung histologic features were evaluated for the presence of endothelial damage, endothelial proliferation and plexiform lesions. Expression of proinflammatory mediators and angiogenic factors in the lung was detected. Matrigel tube formation assay was performed to determine the angiogenic potential of endogenous MSCs. Results: MSC administration reduced cumulative PAH morbidity and attenuated endothelial damage, plexiform lesions and production of inflammatory mediators in the lungs. No significant difference in the expression of paracrine angiogenic factors including VEGF-A and TGF-β was determined between groups, suggesting that they are not essential for the beneficial effect of MSC transplantation. Interestingly, the endogenous MSCs from birds receiving MSC transplantation demonstrated endothelial differentiatial capacity in vitro whereas those from the mock birds did not. Conclusion: Our results support the therapeutic use of MSC transplantation for PAH treatment and suggest that exogenous MSCs produce beneficial effects through modulating inflammation and endogenous MSC-mediated vascular repair. Graphical Abstract: